Blis Technologies Limited logo

Blis Technologies Limited (BLT)

Market Open
7 Aug, 03:45
NZX NZX
NZ$
0. 02
0
0%
NZ$
19.19M Market Cap
- P/E Ratio
- Div Yield
1.11M Volume
- Eps
NZ$ 0.02
Previous Close
Add Transaction
Day Range
0.02 0.02
Year Range
0.01 0.02
Want to track BLT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BLT trading today higher at NZ$0.02, an increase of 0% from yesterday's close, completing a monthly increase of 5.8823% or NZ$0. Over the past 12 months, BLT stock gained 5.8823%.
BLT is not paying dividends to its shareholders.
The last earnings report, released on May 20, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Blis Technologies Limited has completed 2 stock splits, with the recent split occurring on Nov 13, 2007.
The company's stock is traded on one exchange.

BLT Chart

Blis Technologies Limited (BLT) FAQ

What is the stock price today?

The current price is NZ$0.02.

On which exchange is it traded?

Blis Technologies Limited is listed on NZX.

What is its stock symbol?

The ticker symbol is BLT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 19.19M.

Has Blis Technologies Limited ever had a stock split?

Blis Technologies Limited had 2 splits and the recent split was on Nov 13, 2007.

Blis Technologies Limited Profile

Biotechnology Industry
Healthcare Sector
- CEO
NZX Exchange
NZBLTE0002S8 ISIN
New Zealand Country
39 Employees
- Last Dividend
13 Nov 2007 Last Split
- IPO Date

Overview

BLIS Technologies Limited is an innovative company engaged in the development and sale of healthcare products that leverage the power of beneficial bacteria with bacteriocin activity. Focusing on the creation of probiotic formulations, BLIS Technologies targets a variety of health concerns, emphasizing oral and dental health, ear, nose, and throat well-being, and the skin's microbiome. Since its foundation in 2000, the company has expanded its market reach beyond its home base in Dunedin, New Zealand, to include regions such as the Asia Pacific, Europe, the Middle East, Africa, and North America. This global presence underlines its commitment to providing health solutions that are both advanced and accessible worldwide.

Products and Services

BLIS K12

A probiotic supplement designed specifically to support the ear, nose, and throat health of young children. BLIS K12 is also known for its benefits in improving immunity against common infections and in managing bad breath. This strain of bacteria acts as a protective guard, promoting a healthy balance of microflora in children's sensitive ENT areas.

BLIS M18

Developed to maintain and enhance dental health, BLIS M18 is an oral probiotic that supports the health of teeth and gums. Its targeted action helps in the prevention of dental plaque formation, gum disease, and carries a promise of a healthier mouth, contributing to overall dental and oral hygiene and well-being.

BLIS Q24

This probiotic supplement is aimed at caring for the skin by balancing and restoring the skin microbiome. By promoting a healthy bacterial balance on the skin, BLIS Q24 helps in restoring skin health, clarity, and radiance, offering a natural solution for those looking to improve their skin’s appearance and resilience against external factors.

Contact Information

Address: 442 Moray Place
Phone: 64 3 474 0988